BioCentury
ARTICLE | Company News

Glaxo seeks Relenza approval for flu prevention

September 18, 2000 7:00 AM UTC

GLX filed for FDA marketing approval of Relenza zanamivir for the prevention of influenza A and B. The product, which received priority review, was approved to treat influenza last year (see BioCentu...